Baris Yildiz1, Kagan Katar2, Okan Hamamci3. 1. Ankara Numune Teaching Hospital General Surgery, Selanik cad 29/2 Kizilay, Ankara, 06650, Turkey. baris104@yahoo.com. 2. Elbistan State Hospital, Kahramanmaras, Turkey. 3. Ankara Numune Teaching Hospital General Surgery, Selanik cad 29/2 Kizilay, Ankara, 06650, Turkey.
Abstract
PURPOSE: The objective of this study was to analyze the mid-term outcomes of sleeve gastrectomy in a cohort of obese patients. METHODS: We analyzed the outcomes of 159 adult patients who had laparoscopic sleeve gastrectomy between January 2011 and January 2015 in our center. Data collected included patient demographics, presence of comorbid diseases, preoperative body mass index, percent excess weight loss, resolution of comorbid diseases, morbidity and in-hospital mortality. RESULTS: We achieved a 24th month percent excess weight loss of 75.1 ± 10.5. Remission of diabetes mellitus, hypertension, hyperlipidemia and obstructive sleep apnea syndrome after sleeve gastrectomy was as high as 84, 63.9, 75.8 and 93 %, respectively, in different studies. Our results in diabetes mellitus, hypertension and hyperlipidemia are comparable with other data on the improvement of comorbidites after sleeve gastrectomy. We found less improvement in obstructive sleep apnea syndrome in our cohort when compared to other reports. CONCLUSIONS: Sleeve gastrectomy is an efficient, durable technique for the treatment of obesity and associated comorbidities in all body mass index subgroups of obese population. For better outcomes, strategies for proper education and certification are needed.
PURPOSE: The objective of this study was to analyze the mid-term outcomes of sleeve gastrectomy in a cohort of obesepatients. METHODS: We analyzed the outcomes of 159 adult patients who had laparoscopic sleeve gastrectomy between January 2011 and January 2015 in our center. Data collected included patient demographics, presence of comorbid diseases, preoperative body mass index, percent excess weight loss, resolution of comorbid diseases, morbidity and in-hospital mortality. RESULTS: We achieved a 24th month percent excess weight loss of 75.1 ± 10.5. Remission of diabetes mellitus, hypertension, hyperlipidemia and obstructive sleep apnea syndrome after sleeve gastrectomy was as high as 84, 63.9, 75.8 and 93 %, respectively, in different studies. Our results in diabetes mellitus, hypertension and hyperlipidemia are comparable with other data on the improvement of comorbidites after sleeve gastrectomy. We found less improvement in obstructive sleep apnea syndrome in our cohort when compared to other reports. CONCLUSIONS: Sleeve gastrectomy is an efficient, durable technique for the treatment of obesity and associated comorbidities in all body mass index subgroups of obese population. For better outcomes, strategies for proper education and certification are needed.
Authors: Marius Hoogerboord; Shannon Wiebe; Dennis Klassen; Tom Ransom; Diana Lawlor; James Ellsmere Journal: Can J Surg Date: 2014-04 Impact factor: 2.089